May 2025 in “International Journal of Biological and Pharmaceutical Sciences Archive” In an open-label clinical trial, this study found that applying Narasimham Hair Oil thrice weekly for 8 weeks significantly improved hair density, thickness, and scalp health among participants with hair thinning, with benefits persisting after treatment, and 95% reporting user satisfaction without adverse effects.
3 citations
,
June 2023 in “Journal of dermatological treatment” This study found that patients with severe alopecia areata who experienced meaningful scalp hair regrowth showed greater improvements in health-related quality of life and reduced anxiety and depression compared to those with no or minimal regrowth.
November 2025 in “SKIN The Journal of Cutaneous Medicine” This phase 3 trial found that over 50% of adolescents with severe alopecia areata achieved successful hair regrowth after 52 weeks on baricitinib 4-mg, with no new safety concerns reported compared to existing safety profiles.
June 2024 in “JEADV Clinical Practice” This study found that among placebo-treated patients in the BRAVE-AA trials, the likelihood of spontaneous hair regrowth in untreated severe alopecia areata was low, with only a small percentage achieving significant scalp, eyebrow, or eyelash hair improvement over 36 weeks.
In this study, data from multiple sources found that Baricitinib significantly promoted hair regrowth and improved patient-reported outcomes in those with severe alopecia, with minimal side effects, over a 36-week period.